Acute myeloid leukemia of the elderly: results of induction after previous treatment of high-risk myelodysplastic syndrome with a demethylating agent
Blood
2003
101
4
1657-1658
Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers.
Nat Biotechnol
2003
21
5
519-25
Discordant bone marrow involvement in diffuse large B-cell lymphoma: Comparative molecular analysis reveals a heterogeneous group of disorders
Mod Pathol
2003
16
1
240A-241A
Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron
Ann Oncol
2003
14
10
1570-1577
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.
Leukemia
2003
17
12
2392-400
An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma.
Invest New Drugs
2003
21
4
481-6
Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.
J Clin Oncol
2003
21
14
2651-7
Smif/hDcp1a, a co-activator of TGF-beta signalling plays an essential role in RNA decapping and mRNA turnover.
Blood
2003
102
11
835A-835A
Early prediction of tumor response and overall survival in patients with non-small cell lung cancer by FDG-PET.
J Nucl Med
2003
44 Suppl.
5
393P-393P